Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Maxcyte (MXCT) Interest Expenses (2020 - 2022)

Maxcyte (MXCT) has disclosed Interest Expenses for 3 consecutive years, with $11000.0 as the latest value for Q4 2022.

  • Quarterly Interest Expenses changed N/A to $11000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $11000.0 through Sep 2023, down 90.52% year-over-year, with the annual reading at $127000.0 for FY2022, 87.84% down from the prior year.
  • Interest Expenses for Q4 2022 was $11000.0 at Maxcyte, down from $116000.0 in the prior quarter.
  • The five-year high for Interest Expenses was $742300.0 in Q1 2021, with the low at $11000.0 in Q4 2022.
  • Average Interest Expenses over 3 years is $235000.0, with a median of $213950.0 recorded in 2020.
  • Peak annual rise in Interest Expenses hit 9.8% in 2021, while the deepest fall reached 91.99% in 2021.
  • Over 3 years, Interest Expenses stood at $280600.0 in 2020, then increased by 2.99% to $289000.0 in 2021, then tumbled by 96.19% to $11000.0 in 2022.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $11000.0, $116000.0, and $289000.0 for Q4 2022, Q3 2022, and Q3 2021 respectively.